Clinical Trial Update: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2a trial evaluating ENB003 in combination with pembrolizumab for various solid tumors, including melanoma, ovarian cancer, pancreatic cancer, and oth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Melanoma
• Ovarian Cancer
• Pancreatic Cancer
• Solid Tumors

Drugs mentioned

• ENB003
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: ENB Therapeutics, Inc | Conditions: Cancer, Melanoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING